Entrada Therapeutics, Inc. (TRDA)
6.49
-9.54
(-59.51%)
USD |
NASDAQ |
May 07, 13:20
Entrada Therapeutics Profit Margin (Quarterly) : -3.01K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | -- |
| Biogen, Inc. | 13.29% |
| EyePoint, Inc. | -12.19K% |
| Vertex Pharmaceuticals, Inc. | 34.24% |
| Arcutis Biotherapeutics, Inc. | 13.43% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -38.39% |
| Return on Assets | -31.92% |
| Return on Invested Capital | -33.48% |
| Gross Profit Margin (Quarterly) | 31.79% |
| Operating Margin (Quarterly) | -3.25K% |
| Return on Net Operating Assets | -187.1% |